Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia is a research paper published in Blood (2022). On theSindex it has a DataRank of 0.596. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.596
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: UG1 CA232760
NCI NIH HHS
Grant: P30 CA021765
NCI NIH HHS
Grant: R35 CA197695
NCI NIH HHS
Grant: U10 CA180820
NCI NIH HHS
Grant: U24 CA196172
NCI NIH HHS
Grant: T32 CA236748
NCI NIH HHS
Grant: UG1 CA189859
National Institutes of Health
Grant: 3P30CA021765-41S2
Cancer Center Support Grant (CCSG)
National Institutes of Health
Grant: 3U10CA180820-02S3
ECOG-ACRIN Operations Center
National Institutes of Health
Grant: 5UG1CA189859-03
Minority-Based Community Oncology Research Program
National Institutes of Health
Grant: 3UG1CA232760-06S1
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1 (funded extension)
National Institutes of Health
Grant: 5R35CA197695-05
Translating genomic discoveries to improved outcomes for high risk acute leukemia
National Health and Medical Research Council (NHMRC)
Grant: 1140626
Unlocking hidden cancer drivers using transcriptome data
FWCI
9.30
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals